Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 16, 2007 - Issue 7
Submit an article Journal homepage
86
Views
6
CrossRef citations to date
0
Altmetric
Editorial

PPAR-γ inhibitors as novel tubulin-targeting agents

Katherine L Schaefer, PhD Assistant Professor, University of Rochester, Department of Medicine, Gastroenterology and Hepatology Division, 601 Elmwood Avenue, Box 646, Rochester, NY, 14642, USA +1 585 275 8118; +1 585 275 2858; [email protected]
Pages 923-926 | Published online: 26 Jun 2007

Bibliography

  • PETERSON JR, MITCHISON TJ: Small molecules, big impact: a history of chemical inhibitors and the cytoskeleton. Chem. Biol. (2002) 9(12):1275-1285.
  • BHALLA KN: Microtubule-targeted anticancer agents and apoptosis. Oncogene (2003) 22(56):9075-9086.
  • JORDAN MA, WILSON L: Microtubules as a target for anticancer drugs. Nat. Rev. Cancer (2004) 4(4):253-265.
  • SCHAEFER KL, TAKAHASHI H, MORALES VM et al.: PPAR-γ inhibitors reduce tubulin protein levels by a PPAR-γ, PPAR-δ and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cells. Int. J. Cancer (2007) 120(3):702-713.
  • MASUDA T, WADA K, NAKAJIMA A et al.: Critical role of peroxisome proliferator-activated receptor γ on anoikis and invasion of squamous cell carcinoma. Clin. Cancer Res. (2005) 11(11):4012-4021.
  • SCHAEFER KL, WADA K, TAKAHASHI H et al.: Peroxisome proliferator-activated receptor γ inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells. Cancer Res. (2005) 65(6):2251-2259.
  • TAKAHASHI H, FUJITA K, FUJISAWA T et al.: Inhibition of peroxisome proliferator-activated receptor γ activity in esophageal carcinoma cells results in a drastic decrease of invasive properties. Cancer Sci. (2006) 97(9):854-860.
  • RAMILO G, VALVERDE I, LAGO J, VIEITES JM, CABADO AG: Cytotoxic effects of BADGE (bisphenol A diglycidyl ether) and BFDGE (bisphenol F diglycidyl ether) on Caco-2 cells in vitro. Arch. Toxicol. (2006) 80(11):748-755.
  • FEINSTEIN DL, SPAGNOLO A, AKAR C et al.: Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key? Biochem. Pharmacol. (2005) 70(2):177-188.
  • RANGWALA SM, LAZAR MA: Transcriptional control of adipogenesis. Ann. Rev. Nutr. (2000) 20:535-559.
  • PASCUAL G, GLASS CK: Nuclear receptors versus inflammation: mechanisms of transrepression. Trends Endocrinol. Metab. (2006) 17(8):321-327.
  • ARGMANN CA, COCK TA, AUWERX J: Peroxisome proliferator-activated receptor γ: the more the merrier? Eur. J. Clin. Invest. (2005) 35(2):82-92 (Discussion 80).
  • COLCA JR, KLETZIEN RF: What has prevented the expansion of insulin sensitisers? Expert Opin. Investig. Drugs (2006) 15(3):205-210.
  • GIRNUN GD, SPIEGELMAN BM: PPAR-γ ligands: taking part in chemoprevention. Gastroenterology (2003) 124(2):564-567.
  • KOEFFLER HP: Peroxisome proliferator-activated receptor γ and cancers. Clin. Cancer Res. (2003) 9(1):1-9.
  • PANIGRAHY D, HUANG S, KIERAN MW, KAIPAINEN A: PPAR-γ as a therapeutic target for tumor angiogenesis and metastasis. Cancer Biol. Ther. (2005) 4(7):687-693.
  • BURKHART CA, KAVALLARIS M, BAND HORWITZ S: The role of β-tubulin isotypes in resistance to antimitotic drugs. Biochim. Biophys. Acta (2001) 1471(2):O1-O9.
  • KAMATH K, WILSON L, CABRAL F, JORDAN MA: βIII-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability. J. Biol. Chem. (2005) 280(13):12902-12907.
  • FEHLBERG S, GREGEL CM, GOKE A, GOKE R: Bisphenol A diglycidyl ether-induced apoptosis involves Bax/Bid-dependent mitochondrial release of apoptosis-inducing factor (AIF), cytochrome c and Smac/DIABLO. Br. J. Pharmacol. (2003) 139(3):495-500.
  • FEHLBERG S, TRAUTWEIN S, GOKE A, GOKE R: Bisphenol A diglycidyl ether induces apoptosis in tumour cells independently of peroxisome proliferator-activated receptor-γ, in caspase-dependent and -independent manners. Biochem. J. (2002) 362(Part 3):573-578.
  • LEA MA, SURA M, DESBORDES C: Inhibition of cell proliferation by potential peroxisome proliferator-activated receptor (PPAR) γ agonists and antagonists. Anticancer Res. (2004) 24(5A):2765-2771.

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.